Similar articles for PMID: 11773914

Year	Number of Results
1979	1
1983	2
1986	1
1987	1
1988	1
1989	2
1990	1
1991	4
1992	3
1993	1
1994	5
1996	3
1997	4
1998	9
1999	14
2000	12
2001	26
2002	25
2003	30
2004	11
2005	13
2006	6
2007	13
2008	7
2009	6
2010	5
2011	10
2012	8
2013	7
2014	3
2015	2
2016	4
2017	2
2018	4
2019	7
2020	7
2021	9
2022	11
2023	3
2024	1

1

Incidence of high-risk acute coronary syndromes and eligibility for glycoprotein IIb/IIIa inhibitors among patients admitted for possible myocardial ischemia.

Kontos MC, Ornato JP, Schmidt KL, Tatum JL, Jesse RL. Kontos MC, et al. Am Heart J. 2002 Jan;143(1):70-5. doi: 10.1067/mhj.2002.119614. Am Heart J. 2002. PMID: 11773914

2

Impact of the troponin standard on the prevalence of acute myocardial infarction.

Kontos MC, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Kontos MC, et al. Am Heart J. 2003 Sep;146(3):446-52. doi: 10.1016/S0002-8703(03)00245-X. Am Heart J. 2003. PMID: 12947361

3

Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.

Registro Osservazionale Angina Instabile Investigators. Registro Osservazionale Angina Instabile Investigators. Ital Heart J. 2003 Nov;4(11):782-90. Ital Heart J. 2003. PMID: 14699708

4

A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes.

Roe MT, Christenson RH, Ohman EM, Bahr R, Fesmire FM, Storrow A, Mollod M, Peacock WF, Rosenblatt JA, Yang H, Fraulo ES, Hoekstra JW, Gibler WB; EARLY Investigators; Emergency Medicine Cardiac Research and Education Group. Roe MT, et al. Am Heart J. 2003 Dec;146(6):993-8. doi: 10.1016/S0002-8703(03)00517-9. Am Heart J. 2003. PMID: 14660990 Clinical Trial.

5

Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors.

De Luca G, Gibson MC, Hof AW, Cutlip D, Zeymer U, Noc M, Maioli M, Zorman S, Gabriel MH, Secco GG, Emre A, Dudek D, Rakowski T, Gyongyosi M, Huber K, Bellandi F; EGYPT cooperation. De Luca G, et al. J Cardiovasc Med (Hagerstown). 2013 Nov;14(11):815-20. doi: 10.2459/JCM.0b013e32835fcb38. J Cardiovasc Med (Hagerstown). 2013. PMID: 23519096

6

Utility of troponin I in patients with cocaine-associated chest pain.

Kontos MC, Anderson FP, Ornato JP, Tatum JL, Jesse RL. Kontos MC, et al. Acad Emerg Med. 2002 Oct;9(10):1007-13. doi: 10.1111/j.1553-2712.2002.tb02134.x. Acad Emerg Med. 2002. PMID: 12359538 Free article.

7

Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.

Leonardi S, Thomas L, Neely ML, Tricoci P, Lopes RD, White HD, Armstrong PW, Giugliano RP, Antman EM, Califf RM, Newby LK, Mahaffey KW. Leonardi S, et al. J Am Coll Cardiol. 2012 Dec 4;60(22):2296-304. doi: 10.1016/j.jacc.2012.09.005. Epub 2012 Nov 1. J Am Coll Cardiol. 2012. PMID: 23122801 Free article. Clinical Trial.

8

Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: study design of the sibrafiban versus aspirin to yield maximum protection from ischemic heart events post-acute coronary syndromes (SYMPHONY) trial. Symphony Steering Committee.

Newby LK. Newby LK. Am Heart J. 1999 Aug;138(2 Pt 1):210-8. doi: 10.1016/s0002-8703(99)70104-3. Am Heart J. 1999. PMID: 10426831

9

Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.

Alexander JH, Sparapani RA, Mahaffey KW, Deckers JW, Newby LK, Ohman EM, Corbalán R, Chierchia SL, Boland JB, Simoons ML, Califf RM, Topol EJ, Harrington RA. Alexander JH, et al. JAMA. 2000 Jan 19;283(3):347-53. doi: 10.1001/jama.283.3.347. JAMA. 2000. PMID: 10647797

10

Impacts of glycoprotein IIb/IIIa inhibition on QT dispersion after successful percutaneous coronary intervention.

Okmen E, Sanli A, Uyarel H, Dayi S, Tartan Z, Cam N. Okmen E, et al. Angiology. 2006 May-Jun;57(3):273-81. doi: 10.1177/000331970605700303. Angiology. 2006. PMID: 16703187 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

271 results

Results by year